Status:
COMPLETED
Using Novel Canadian Resources to Improve Medication Reconciliation at Discharge
Lead Sponsor:
McGill University
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Conditions:
Medication Reconciliation
Adverse Drug Events
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine if a physician's use of electronic medication reconciliation software when writing a patient's discharge prescription will prevent adverse drug events and rea...
Detailed Description
Background: * Drug-related illness accounts for 5-23% of hospital admissions, 4-8% of ambulatory visits, and is now claimed to be the 6th leading cause of mortality. * At least 58% of adverse drug ev...
Eligibility Criteria
Inclusion
- have public drug insurance: this includes all those 65 years and older in the province of Quebec, as well as those under 65 on social assistance or who do not have drug insurance available through their employer
- admitted to the hospital from the community
- admitted to a surgical or internal medicine unit
- discharged alive
Exclusion
- \- none
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2019
Estimated Enrollment :
4014 Patients enrolled
Trial Details
Trial ID
NCT01179867
Start Date
October 1 2014
End Date
August 1 2019
Last Update
August 20 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McGill University Health Centre
Montreal, Quebec, Canada, H3A 1A3